Takeda Pharmaceutical Company Limited

TKPHF ·Healthcare, Drug Manufacturers - General, Japan
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
3 Mar 18, 2026 FORM 3
3 Mar 18, 2026 FORM 3
3 Mar 18, 2026 FORM 3
3 Mar 18, 2026 FORM 3
3 Mar 18, 2026 FORM 3
3 Mar 18, 2026 FORM 3
6-K Mar 2, 2026 6-K
6-K Feb 10, 2026 6-K
6-K Jan 29, 2026 6-K
6-K Dec 18, 2025 6-K
4 Dec 9, 2025 FORM 4
SCHEDULE 13G/A Dec 9, 2025
144 Dec 9, 2025
6-K Dec 8, 2025 6-K
144 Dec 5, 2025
144 Dec 4, 2025
6-K Nov 28, 2025 6-K
13F-HR Nov 13, 2025
6-K Oct 30, 2025 6-K
6-K Oct 30, 2025 6-K
6-K Oct 30, 2025 6-K
6-K Oct 1, 2025 6-K
6-K Sep 25, 2025 6-K
4 Sep 19, 2025 FORM 4
SCHEDULE 13D/A Sep 19, 2025
← Newer Page 6 of 29 · 704 filings Older →